BioSpace News Archive

Business

CytoDyn Appoints Michael A. Klump to Board of Directors

CytoDyn Inc. announces that Michael A. Klump, President and Chief Executive Officer of Argonne Capital Group, has joined the CytoDyn Board of Directors.

August 13, 2018
·
8 min read
BioForest

Medicaid Can Save More than $4.8 Billion by Moving to Fully Electronic Transactions

State agencies and health plans covering 44% of all Medicaid enrollees demonstrate commitment to automation, efficient processes through CORE Certification; remaining payers have an opportunity for savings, operational improvements

August 13, 2018
·
12 min read
Deals

WellCare Announces Closing of 5,207,547 Shares of Its Common Stock Offering

WellCare Health Plans, Inc. (NYSE: WCG) announced today that on August 10, 2018 it closed an offering of 5,207,547 shares of its common stock at a public offering price of $265.00 per share

August 13, 2018
·
4 min read
Business

Accelerator Life Science Partners Launches Magnolia Neurosciences Corporation with $31 Million Series A to Develop Targeted Neuroprotective Therapies

Accelerator Life Science Partners announced that it has launched Magnolia Neurosciences Corporation, a company developing a new class of neuroprotective medicines.

August 13, 2018
·
5 min read
Business

UF Innovate | Sid Martin Biotech Resident Company Lacerta Therapeutics, Inc. Closes On $30 million Investment Round

UF Innovate | Sid Martin Biotech, the leading biotechnology incubator at the University of Florida, announces resident company Lacerta Therapeutics, Inc., has closed on a $30 million investment round.

August 13, 2018
·
3 min read
Business

WellNet Healthcare Hires Five Additional Business Development Executives

Reflective of Growth of Small and Mid-Size Businesses Selecting Level-Funded and Self-Funded Plans in 2018 and 2019

August 13, 2018
·
2 min read
Business

Linda Mignone Joins Ultimate Medical Academy as Chief Marketing Officer

Linda Mignone has joined Ultimate Medical Academy as Chief Marketing Officer.

August 13, 2018
·
1 min read
Business

Cellect and Cell2in Launch Collaboration to Significantly Improve Stem Cell Selection and Expansion

Aim is to combine the benefits of mutual technologies to enable higher quality cells at a lower cost

August 13, 2018
·
5 min read
Business

BioLineRx Reports Second Quarter 2018 Financial Results

BioLineRx Ltd. reports its financial results for the second quarter ended June 30, 2018.

August 13, 2018
·
29 min read
Policy

Regeneron Provides Regulatory Update on EYLEA® (aflibercept) Injection sBLA in Wet Age-Related Macular Degeneration

Regeneron Pharmaceuticals, Inc. announced that due to ongoing labeling discussions the U.S. Food and Drug Administration (FDA) has issued a complete response letter (CRL) regarding the supplemental Biologics License Application (sBLA) for EYLEA® (aflibercept)

August 13, 2018
·
10 min read